Mycobacterium tuberculosis Complex Drug Resistance in Italy [1]

Emerging Infectious Diseases

Volumn 10, Issue 4, 2004, Pages 752-753

  Migliori, Giovanni B ^a   Centis, Rosella ^a   Fattorini, Lanfranco ^a   Besozzi, Giorgio ^a   Saltini, Cesare ^a   Scarparo, Claudio ^a   Cirillo, Daniela ^a   Gori, Andrea ^a   Cassone, Antonio ^a   Piersimoni, Claudio ^a,b  

^a SMIRA   (Italy)

^b Azienda Ospedaliera Umberto I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; DRUG SURVEILLANCE PROGRAM; HUMAN; ITALY; LETTER; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; TUBERCULOSIS;

EID: 12144287931     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1004.030667     Document Type: Letter

References (10)

1. Kochi A, Vareldzis B, Styblo K. Multidrug-resistant tuberculosis and its control. Res Microbiol 1993;144:104-10.
2. Anti-tuberculosis drug resistance in the world. The WHO/IUATLD Global Project on anti-tuberculosis drug resistance surveillance. World Health Organization, Geneva, 1997. WHO/TB/97.229:1-227.
3. WHO/IUATLD Global Working Group on antituberculosis drug resistant surveillance. Guidelines for surveillance of drug resistance in tuberculosis. World Health Organization, Geneva, 1997. WHO/TB/96.216:1-36.
4. Centis R, Ianni A, Migliori GB, on behalf of the Tuberculosis section of the National AIPO Study Group and the SMIRA Group. Evaluation of tuberculosis treatment results in Italy, report 1998. Monaldi Arch Chest Dis 2000;55:293-8.
5. Migliori GB, Ambrosetti M, Fattorini L, Penati V, Vaccarino P, Besozzi G, et al. Surveillance of anti-tuberculosis drug resistance: results of the 1998/1999 proficiency testing in Italy. Int J Tuberc Lung Dis 2000;4:940-6.
6. Canetti G. Quelques imprécisions dans les méthodes couramment employée pour la détermination de l'isoniazido-résistance du bacille tuberculeux, leur ampleur et leur inconvénients. Bull Int Union Tuberc 1955;25:157-78.
7. Roberts GD, Goodman NL, Heifets L, Larsh HW, Lindner TH, McClatchy JK, et al. Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J Clinic Microbiol 1983;18:689-96.
8. Rusch-Gerdes S, Domehl C, Nardi G, Gismondo MR, Welscher HM, Pfyffer GE. Multicenter evaluation of the mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs. J Clin Microbiol 1999;37:45-8.
9. Laszlo A, Rahman M, Raviglione MC, Bustreo F, and the WHO/IUATLD Network of Supranational Reference Laboratories. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. Int J Tuberc Lung Dis 1997;1:231-8.
10. Garcia de Viedma D. Rapid detection of resistance in Mycobacterium tuberculosis: a review discussing molecular approach. Clin Microbiol Infect 2003;9:349-59.